Imbalance between Th17 and treg cells may play an important role in the development of chronic unpredictable mild stress-induced depression in mice

NeuroImmunoModulation

Volumn 20, Issue 1, 2012, Pages 39-50

  Hong, Min ^a   Zheng, Jie ^c   Ding, Zhao Yun ^a   Chen, Jun Hao ^b   Yu, Liangyan ^a   Niu, Yan ^a   Hua, Yong Qing ^a   Wang, Ling Ling ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Chronic unpredictable mild stress; Depression; TGF ; Th17; Treg

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIDEPRESSANT AGENT; CD3 ANTIGEN; HTS 466284; INTERLEUKIN 23; INTERLEUKIN 4; MESSENGER RNA; RECEPTOR BLOCKING AGENT; SUCROSE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CELL ASSAY; CHRONIC STRESS; CONTROLLED STUDY; CULTURE MEDIUM; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; FOOD PREFERENCE; GENE EXPRESSION REGULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; SUGAR INTAKE; TH17 CELL;

ANIMALS; CYTOKINES; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOPHENOTYPING; MALE; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84869231149     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000343100     Document Type: Article

References (51)

1. World Health Organization: The Global Burden of Disease: 2004 Update. 2008, p 153.
2. Schildkraut JJ: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122: 509-522.
3. Steffens DC, Byrum CE, McQuoid DR, Greenberg DL, Payne ME, Blitchington TF, MacFall JR, Krishnan KR: Hippocampal volume in geriatric depression. Bio Psychiatry 2000; 48: 301-309. (Pubitemid 30645800)
4. Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R: Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. J Psychiatry Neurosci 2004; 29: 208-218. (Pubitemid 38829857)
5. Elhwuegi AS: Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 435-451. (Pubitemid 38490755)
6. Scholl JL, Renner KJ, Forster GL, Tejani-Butt S: Central monoamine levels differ between rat strains used in studies of depressive behavior. Brain Res 2010; 1355: 41-51.
7. Irwin MR, Miller AH: Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007; 21: 374-383. (Pubitemid 46528684)
8. Blume J, Douglas SD, Evans DL: Immune suppression and immune activation in depression. Brain Behav Immun 2011; 25: 221-229.
9. Dunn A J, Swiergiel A H, de Beacurepaire R: Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 2005; 29: 891-909. (Pubitemid 40755469)
10. Maes M, Scharpe S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche BV, Cosyns P: Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res 1994; 54: 143-160.
11. Zorrilla EP, Luborsky L, Mckay JR, et al: The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001; 15: 199-226. (Pubitemid 33070955)
12. Glaser R, Kiecolt-Glaser JK: Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005; 5: 243-251. (Pubitemid 40364825)
13. Saul AN, Oberyszyn TM, Daugherty C, Kusewitt D, Jones S, Jewell S, Malarkey WB, Lehman A, Lemeshow S, Dhabhar FS: Chronic stress and susceptibility to skin cancer. J Natl Cancer Inst 2005; 97: 1760-1767. (Pubitemid 41782285)
14. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H: Cytokine production and serum proteins in depression. Scand J Immunol 1995; 41: 534-538.
15. Myint AM, Leonard BE, Steinbusch HW, Kim YK: Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 2005; 88: 167-173. (Pubitemid 41266899)
16. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, Sanisoglu SY, Yesilova Z, Ozmenler N, Ozsahin A, Sengul A: Proand anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007; 2007: 76396.
17. Miller AH: Depression and immunity: a role for T cells? Brain Behav Immun 2010; 24: 1-8.
18. Schleifer SJ, Keller SE, Bond RN, Cohen J, Stein M: Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry 1989; 46: 81-87. (Pubitemid 19038411)
19. Pal SN, Dandiya PC: Comparative study of diazepam, mapratroline, fluvoxamine, trazodone and alprazolam in some animal models of depression. Indian J Pharmacol 1993; 25: 204-208.
20. Nirmal J, Babu CS, Harisudhan T, Ramanathan M: Evaluation of behavioural and antioxidant activity of Cytisus scoparius Link in rats exposed to chronic unpredictable mild stress. BMC Complement Altern Med 2008; 8: 15.
21. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R: Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987; 93: 358-364. (Pubitemid 17160661)
22. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, Luger D, Nussenblatt RB, Caspi RR: Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 2008; 180: 5167-5171.
23. Li Q, Furman SA, Bradford CR, Chang AE: Expanded tumor-reactive CD4+ T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation. Clin Cancer Res 1999; 5: 461-469. (Pubitemid 29085202)
24. McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, Blumenschein WM, Mc-Clanahan TK, O'Shea JJ, Cua DJ: The interleukin receptor is essential for terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 2009; 10: 314-324.
25. Ouyang Y, Miyata M, Hatsushika K, Ohnuma Y, Katoh R, Ogawa H, Okumura K, Masuyama K, Nakao A: TGF-beta signaling may play a role in the development of goblet cell hyperplasia in a mouse model of allergic rhinitis. Allergol Int 2010; 59: 313-319.
26. Leonard BE: The concept of depression as a dysfunction of the immune system. Curr Immunol Rev 2010; 6: 205-212.
27. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995; 34: 301-309.
28. Raison C L, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31. (Pubitemid 43083561)
29. Frasure-Smith N, Lespérance F, Irwin MR, Sauvé C, Lespérance J, Théroux P: Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Bio Psychiatry 2007; 62: 302-308. (Pubitemid 47444279)
30. Willner P: Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog Neuropsychopharmacol Biol Psychiatry 1986; 10: 677-690. (Pubitemid 17185919)
31. Willner P: Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52: 90-110. (Pubitemid 41160326)
32. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-53.
33. Medzhitov R, Janeway CA Jr: Innate immune recognition and control of adaptive immune responses. Semin Immunol 1998; 10: 351-353. (Pubitemid 28499548)
34. Del Prete G: Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 1992; 47: 450-455.
35. Schwarz M J, Chiang S, Müller N, Ackenheil M: T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav Immun 2001; 15: 340-370. (Pubitemid 34044520)
36. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H: Increased CD56+ natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 1996; 78: 83-85. (Pubitemid 26078315)
37. Mendlovic S, Mozes E, Eilat E, Doron A, Lereya J, Zakuth V, Spirer Z: Immune activation in non-treated suicidal major depression. Immunol Lett 1999; 67: 105-108. (Pubitemid 29191527)
38. Kubo M, Yamashita M, Abe R, Tada T, Okumura K, Ransom J T, Nakayama T: CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation. J Immunol 1999; 163: 2432-2442. (Pubitemid 29399162)
39. Kim YK, Na KS, Shin KH, et al: Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1044-1053.
40. Pavón L, Sandoval-López G, Eugenia-Hernández M, Loría F, Estrada I, Pérez M, Moreno J, Avila U, Leff P, Antón B, Heinze G: Th2 cytokine response in Major Depressive Disorder patients before treatment. J Neuroimmunol 2006; 172: 156-165. (Pubitemid 43277501)
41. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-240. (Pubitemid 40189432)
42. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13: 715-725.
43. Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA: The development and function of regulatory T cells. Cell Mol Life Sci 2009; 66: 2603-2622.
44. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56. (Pubitemid 350295688)
45. Witowski J, Ksiazek K, Jörres A: Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 2004; 61: 567-579. (Pubitemid 38372911)
46. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M, Krueger JG: Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004; 199: 125-130. (Pubitemid 38076484)
47. McKenzie BS, Kastelein RA, Cua DJ: Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006; 27: 17-23. (Pubitemid 43083560)
48. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM: Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-688. (Pubitemid 43867371)
49. Weaver CT, Hatton RD, Mangan PR, Harrington LE: IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852. (Pubitemid 46697925)
50. Kimura A, Kishimoto T: Th17 cells in inflammation. Int Immunopharmacol 2011; 11: 319-322.
51. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR: TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453: 236-240. (Pubitemid 351667978)